鉴定 T 细胞急性淋巴细胞白血病 RT-qPCR 中的内源性对照 miRNAs。
Identification of Endogenous Control miRNAs for RT-qPCR in T-Cell Acute Lymphoblastic Leukemia.
机构信息
Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznań, Poland.
Department, Silesian University of Technology, 44-100 Gliwice, Poland.
出版信息
Int J Mol Sci. 2018 Sep 20;19(10):2858. doi: 10.3390/ijms19102858.
Optimal endogenous controls enable reliable normalization of microRNA (miRNA) expression in reverse-transcription quantitative PCR (RT-qPCR). This is particularly important when miRNAs are considered as candidate diagnostic or prognostic biomarkers. Universal endogenous controls are lacking, thus candidate normalizers must be evaluated individually for each experiment. Here we present a strategy that we applied to the identification of optimal control miRNAs for RT-qPCR profiling of miRNA expression in T-cell acute lymphoblastic leukemia (T-ALL) and in normal cells of T-lineage. First, using NormFinder for an iterative analysis of miRNA stability in our miRNA-seq data, we established the number of control miRNAs to be used in RT-qPCR. Then, we identified optimal control miRNAs by a comprehensive analysis of miRNA stability in miRNA-seq data and in RT-qPCR by analysis of RT-qPCR amplification efficiency and expression across a variety of T-lineage samples and T-ALL cell line culture conditions. We then showed the utility of the combination of three miRNAs as endogenous normalizers (hsa-miR-16-5p, hsa-miR-25-3p, and hsa-let-7a-5p). These miRNAs might serve as first-line candidate endogenous controls for RT-qPCR analysis of miRNAs in different types of T-lineage samples: T-ALL patient samples, T-ALL cell lines, normal immature thymocytes, and mature T-lymphocytes. The strategy we present is universal and can be transferred to other RT-qPCR experiments.
优化的内参控制可实现逆转录定量 PCR (RT-qPCR) 中 miRNA 表达的可靠标准化。当 miRNA 被视为候选诊断或预后生物标志物时,这一点尤为重要。目前缺乏通用的内参,因此必须针对每个实验单独评估候选内参。本文介绍了一种应用于鉴定 T 细胞急性淋巴细胞白血病 (T-ALL) 和 T 细胞系正常细胞中 miRNA 表达 RT-qPCR 分析的最优内参 miRNA 的策略。首先,我们使用 NormFinder 对 miRNA-seq 数据中的 miRNA 稳定性进行迭代分析,确定用于 RT-qPCR 的内参 miRNA 数量。然后,我们通过分析 miRNA-seq 数据和 RT-qPCR 中 miRNA 稳定性,以及通过分析各种 T 细胞系样本和 T-ALL 细胞系培养条件下的 RT-qPCR 扩增效率和表达,综合鉴定最优内参 miRNA。随后,我们展示了三个 miRNA 组合作为内参的实用性 (hsa-miR-16-5p、hsa-miR-25-3p 和 hsa-let-7a-5p)。这些 miRNA 可能成为不同类型 T 细胞系样本 (T-ALL 患者样本、T-ALL 细胞系、未成熟的胸腺细胞和成熟的 T 淋巴细胞) 中 RT-qPCR 分析 miRNA 的一线候选内参。我们提出的策略具有通用性,可应用于其他 RT-qPCR 实验。